PathogenDx, Inc., an Arizona-based technology company, announced a distribution agreement with Axiology Labs, a South African-based laboratory equipment supply company, for its breakthrough Detectx-Cv ...
(MENAFN- Newsfile Corp) PathogenDx Announces the CE Marking of Its Next-Generation COVID-19 Testing Technology for the Simultaneous Detection of SARS-CoV-2 (COVID-19) and Its Variants The Technology ...
PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains SANTA CLARA, Calif., March 22, 2021 ...
SCOTTSDALE, Ariz., Dec. 21, 2020 /PRNewswire/ -- PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today ...
The Technology Provides Medical Laboratories with a Rapid (6 hours), Affordable and Accurate Test for the Detection of SARS-CoV-2 ("COVID-19") and its Variants ("VOC") and ("VOI") without Sequencing ...
PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains "PathogenDx's testing technology harnesses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results